Cargando…

Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients

In order to evaluate the possible role of the proteolytic enzyme cathepsin B (cath B) in human non-small cell lung cancer (NSCLC) we examined cath B concentrations (cath B(c)) and activities (cath B(A)) in homogenates of 127 pairs of lung tumour tissues and corresponding non-tumourous lung parenchym...

Descripción completa

Detalles Bibliográficos
Autores principales:	Werle, B, Lötterle, H, Schanzenbächer, U, Lah, T T, Kalman, E, Kayser, K, Bülzebruck, H, Schirren, J, Krasovec, M, Kos, J, Spiess, E
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1999
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362911/ https://www.ncbi.nlm.nih.gov/pubmed/10507778 http://dx.doi.org/10.1038/sj.bjc.6690723

Ejemplares similares

Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking
por: Schweiger, A, et al.
Publicado: (2000)

Cathepsin S in tumours, regional lymph nodes and sera of patients with lung cancer: relation to prognosis
por: Kos, J, et al.
Publicado: (2001)

Cathepsin B fraction active at physiological pH of 7.5 is of prognostic significance in squamous cell carcinoma of human lung.
por: Werle, B., et al.
Publicado: (1997)

Cathepsins B, L and cystatin C in cyst fluid of ovarian tumors
por: Kolwijck, Eva, et al.
Publicado: (2009)

Upregulation of Cathepsin X in Glioblastoma: Interplay with γ-Enolase and the Effects of Selective Cathepsin X Inhibitors
por: Majc, Bernarda, et al.
Publicado: (2022)

Localization Patterns of Cathepsins K and X and their Predictive Value in Glioblastoma
por: Breznik, Barbara, et al.
Publicado: (2018)

Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity
por: Cooper, R A, et al.
Publicado: (1999)

Alterations in cathepsin H activity and protein patterns in human colorectal carcinomas
por: Re, E C del, et al.
Publicado: (2000)

Individualized faecal immunochemical test cut-off based on age and sex in colorectal cancer screening
por: Kortlever, Tim L., et al.
Publicado: (2021)

Cathepsin D Inhibits Angiogenesis in Pituitary Neuroendocrine Tumors
por: Fujiwara, Ren, et al.
Publicado: (2022)

Reach and effectiveness of a centralized navigation program for patients with positive fecal immunochemical tests requiring follow-up colonoscopy
por: O'Leary, Meghan C., et al.
Publicado: (2023)

RCAS1 as a tumour progression marker: an independent negative prognostic factor in gallbladder cancer
por: Oshikiri, T, et al.
Publicado: (2001)

Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients
por: Foekens, J A, et al.
Publicado: (1999)

The fecal immunochemical test (fit): Selected aspects regarding its effectiveness for colorectal cancer screening in Quebec City
por: Caron, Mireille, et al.
Publicado: (2018)

Cysteine cathepsins B, X and K expression in peri-arteriolar glioblastoma stem cell niches
por: Breznik, Barbara, et al.
Publicado: (2018)

Time at surgery during menstrual cycle and menopause affects pS2 but not cathepsin D levels in breast cancer
por: Pujol, P, et al.
Publicado: (1999)

Low levels of cathepsin D are associated with a poor prognosis in endometrial cancer
por: Falcón, O, et al.
Publicado: (1999)

New Insights into the Role of Cysteine Cathepsins in Neuroinflammation
por: Pišlar, Anja, et al.
Publicado: (2021)

Expression of the novel tumour suppressor p33(ING1) is independent of p53
por: Cheung, K-J J, et al.
Publicado: (2000)

Immunochemical protocols
Publicado: (1998)

Cysteine Cathepsins in Tumor-Associated Immune Cells
por: Jakoš, Tanja, et al.
Publicado: (2019)

Vascular endothelial growth factor expression is independent of hypoxia in human malignant glioma spheroids and tumours
por: Parliament, M B, et al.
Publicado: (2000)

Barriers associated with inadequate follow-up of abnormal fecal immunochemical test results in a safety-net system: A mixed-methods analysis
por: Issaka, Rachel B., et al.
Publicado: (2022)

Immunochemical techniques in biological monitoring.
por: Rosner, M H, et al.
Publicado: (1991)

Cysteine Cathepsins as Regulators of the Cytotoxicity of NK and T Cells
por: Perišić Nanut, Milica, et al.
Publicado: (2014)

Activation and activities of the p53 tumour suppressor protein
por: Bálint, É, et al.
Publicado: (2001)

Serological and Immunochemical Studies on the Gonadotrophic Hormones
por: Chase, Jeanne H.
Publicado: (1945)

Cathepsin B and Muscular Strength are Independently Associated with Cognitive Control
por: Kim, Jeongwoon, et al.
Publicado: (2022)

Enhanced Autophagy and Reduced Expression of Cathepsin D Are Related to Autophagic Cell Death in Epstein-Barr Virus-Associated Nasal Natural Killer/T-Cell Lymphomas: An Immunohistochemical Analysis of Beclin-1, LC3, Mitochondria (AE-1), and Cathepsin D in Nasopharyngeal Lymphomas
por: Hasui, Kazuhisa, et al.
Publicado: (2011)

Cysteine Cathepsins as Therapeutic Targets in Immune Regulation and Immune Disorders
por: Senjor, Emanuela, et al.
Publicado: (2023)

Comparative genomic hybridization and chromosomal instability in solid tumours
por: Rooney, P H, et al.
Publicado: (1999)

Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity
por: Bennewith, K L, et al.
Publicado: (2001)

Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines
por: Tilborg, A A G van, et al.
Publicado: (1999)

Immunochemical characterization of brain and pineal tryptophan hydroxylase.
por: Chung, Y. I., et al.
Publicado: (2001)

Limited neuropeptide Y precursor processing in unfavourable metastatic neuroblastoma tumours
por: Bjellerup, P, et al.
Publicado: (2000)

Risk factors for testicular germ cell tumours by histological tumour type
por: Coupland, C A C, et al.
Publicado: (1999)

Inhibition of apoptosis in human tumour cells by the tumour-associated serpin, SCC antigen-1
por: Suminami, Y, et al.
Publicado: (2000)

No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours
por: Jefferies, S, et al.
Publicado: (2001)

Cathepsin-B and cathepsin-L expression levels do not correlate with sensitivity of tumour cells to TNF-α-mediated apoptosis
por: Gewies, A, et al.
Publicado: (2003)

Evaluation of novel cathepsin-X inhibitors in vitro and in vivo and their ability to improve cathepsin-B-directed antitumor therapy
por: Mitrović, Ana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lgld26f2ervc5bhd82dfa8aatg